JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 32 No. 4 726-728
© 1991 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mineura, K.
Right arrow Articles by Shishido, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mineura, K.
Right arrow Articles by Shishido, F.

Innovative Approach in the Diagnosis of Gliomatosis Cerebri Using Carbon-11-L-Methionine Positron Emission Tomography

Katsuyoshi Mineura, Toshio Sasajima, Masayoshi Kowada, Yoshiyuki Uesaka and Fumio Shishido

Neurosurgical Service and Department of Pathology, Akita University Hospital, and Department of Radiology and Nuclear Medicine, Research Institute for Brain and Blood Vessels-Akita, Akita, Japan

Correspondence: For reprints contact: Katsuyoshi Mineura, MD, Neurosurgical Service, Akita University Hospital, 1-1-1 Hondo, Akita 010 Japan.

ABSTRACT

A case of gliomatosis cerebri was studied with positron emission tomography (PET). Carbon-11-L-methionine (11C-Met) accumulated in the diffusely infiltrative tumorous area more widely and accurately than the lesion detected by conventional x-ray computerized tomography (CT) or magnetic resonance (MR) imaging. Autopsy findings three months after the time of the PET study showed good anatomical correspondence between the extent of densely aggregated tumor cells and the region with high uptake of 11C-Met. PET may offer an innovative approach in the delineation of gliomatosis cerebri, which has not been clearly recognized by CT or MR.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D S Rosenberg, G Demarquay, A Jouvet, D Le Bars, N Streichenberger, M Sindou, N Kopp, F Mauguiere, and P Ryvlin
[11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms
J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1686 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. W. Kracht, H. Miletic, S. Busch, A. H. Jacobs, J. Voges, M. Hoevels, J. C. Klein, K. Herholz, and W.-D. Heiss
Delineation of Brain Tumor Extent with [11C]L-Methionine Positron Emission Tomography: Local Comparison with Stereotactic Histopathology
Clin. Cancer Res., November 1, 2004; 10(21): 7163 - 7170.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. Pirotte, S. Goldman, N. Massager, P. David, D. Wikler, A. Vandesteene, I. Salmon, J. Brotchi, and M. Levivier
Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of Gliomas
J. Nucl. Med., August 1, 2004; 45(8): 1293 - 1298.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. L. Jager, W. Vaalburg, J. Pruim, E. G.E. de Vries, K.-J. Langen, and D. A. Piers
Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology
J. Nucl. Med., March 1, 2001; 42(3): 432 - 445.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1991 by the Society of Nuclear Medicine.